Medpace Holdings, Inc. MEDP
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.84B | 2.78B | 2.68B | 2.53B | 2.36B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.84B | 2.78B | 2.68B | 2.53B | 2.36B |
| Cost of Revenue | 787.83M | 769.32M | 752.59M | 732.13M | 717.50M |
| Gross Profit | 2.05B | 2.01B | 1.93B | 1.80B | 1.64B |
| SG&A Expenses | 192.70M | 189.02M | 187.58M | 197.56M | 198.08M |
| Depreciation & Amortization | 27.33M | 27.80M | 28.10M | 28.12M | 28.50M |
| Other Operating Expenses | 1.22B | 1.21B | 1.15B | 1.04B | 907.26M |
| Total Operating Expenses | 2.23B | 2.20B | 2.12B | 2.00B | 1.85B |
| Operating Income | 607.14M | 583.40M | 562.92M | 534.94M | 507.04M |
| Income Before Tax | 626.99M | 598.92M | 571.80M | 542.38M | 519.43M |
| Income Tax Expenses | 109.17M | 107.42M | 111.40M | 91.25M | 86.42M |
| Earnings from Continuing Operations | 517.83 | 491.50 | 460.40 | 451.12 | 433.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 517.83M | 491.50M | 460.40M | 451.12M | 433.01M |
| EBIT | 607.14M | 583.40M | 562.92M | 534.94M | 507.04M |
| EBITDA | 634.46M | 611.20M | 591.02M | 563.06M | 535.54M |
| EPS Basic | 18.36 | 17.39 | 16.24 | 15.65 | 14.66 |
| Normalized Basic EPS | 13.90 | 13.24 | 12.60 | 11.79 | 11.03 |
| EPS Diluted | 18.03 | 17.05 | 15.90 | 15.29 | 14.30 |
| Normalized Diluted EPS | 13.65 | 12.99 | 12.34 | 11.52 | 10.76 |
| Average Basic Shares Outstanding | 112.85M | 113.05M | 113.47M | 115.42M | 118.07M |
| Average Diluted Shares Outstanding | 114.85M | 115.30M | 115.89M | 118.12M | 121.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |